The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
Probenecid has been studied across 18 research domains including 🫘 Kidney, 🧠 Focus & Attention, 🦴 Bone & Joint, 🫁 Liver & Detox, 🌤️ Mood & Depression. The primary research focus is 🫘 Kidney with 21% of studies addressing this area.
The following compounds share molecular targets with Probenecid, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Probenecid is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.